Ferguson, GB
Andrew Ferguson, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20090309229 | Silicon single electron device - A silicon integrated circuit device comprising a near intrinsic silicon substrate in which there are one or more ohmic contact regions. An insulating layer lies above the substrate, and on top of the insulating layer is a lower layer of one or more aluminium gates. The surface of each of the lower gates is oxidised to insulate them from an upper aluminium gate that extends over the lower gates. | 12-17-2009 |
Christopher Ferguson, Hartlepool GB
Patent application number | Description | Published |
---|---|---|
20090047596 | Donor element with release-modifier for thermal transfer - A donor element useful in an assemblage for imaging by exposure to light comprises a support layer, a light-to-heat conversion layer disposed adjacent the support layer containing a light absorber, and a transfer layer disposed adjacent the light-to-heat conversion layer opposite the support layer. The donor element also includes a release-modifier disposed between the support layer and the transfer layer. | 02-19-2009 |
20090047597 | Donor element for radiation-induced thermal transfer - A donor element useful in an assemblage for imaging by exposure to radiation comprises a substrate, a transfer-assist layer disposed adjacent the substrate comprising one or more water-soluble or water-dispersible radiation-absorbing compound(s), and a transfer layer disposed adjacent the transfer-assist layer opposite the substrate. | 02-19-2009 |
20110244390 | DONOR ELEMENT WITH MALEIC ANHYDRIDE BASED POLYMERS FOR THERMAL TRANSFER - This invention pertains to a donor element for use with a receiver element in an imagable assemblage for light-induced transfer of material from the donor element to the receiver element. Specifically, this invention relates to such a donor element comprising a copolymer based on styrene and maleic anhydride. | 10-06-2011 |
Colin T. Ferguson, Lanarkshire GB
Patent application number | Description | Published |
---|---|---|
20100145528 | CONTRLLER INTERFACE WITH MULTIPLE DAY PROGRAMMING - A controller equipped with a user interface having multiple-day programming capabilities, including methods of programming such devices, are disclosed. The user interface may include one or more menus or screens that can be used to program a schedule for one or more selected days during the week. An illustrative method of programming the controller may include the steps of entering a scheduling routine, selecting multiple days for schedule modification, changing the schedule parameters for one or more periods during the selected days, and then exiting the scheduling routine. | 06-10-2010 |
20110160915 | CONTROLLER INTERFACE WITH MULTIPLE DAY PROGRAMMING - A controller equipped with a user interface having multiple-day programming capabilities, including methods of programming such devices, are disclosed. The user interface may include one or more menus or screens that can be used to program a schedule for one or more selected days during the week. An illustrative method of programming the controller may include the steps of entering a scheduling routine, selecting multiple days for schedule modification, changing the schedule parameters for one or more periods during the selected days, and then exiting the scheduling routine. | 06-30-2011 |
20130018486 | CONTRLLER INTERFACE WITH MULTIPLE DAY PROGRAMMING - A controller equipped with a user interface having multiple-day programming capabilities, including methods of programming such devices, are disclosed. The user interface may include one or more menus or screens that can be used to program a schedule for one or more selected days during the week. An illustrative method of programming the controller may include the steps of entering a scheduling routine, selecting multiple days for schedule modification, changing the schedule parameters for one or more periods during the selected days, and then exiting the scheduling routine. | 01-17-2013 |
David S. Ferguson, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20140089467 | CONTENT STREAM DELIVERY USING PRE-LOADED SEGMENTS - A method comprises receiving a first request for a first segment of a content stream in a network element from a given one of a plurality of clients, determining in the network element whether the first segment is stored in a memory of the network element, sending a second request for the first segment from the network element to a server responsive to the determining step, receiving a response comprising the first segment in the network element from the server responsive to the second request, and sending the first segment from the network element to the given one of the plurality of clients. The first segment is related to a second segment of the content stream, the relationship being transparent to the network element but being inferable based at least in part on at least one of the first request, the response and one or more prior requests. | 03-27-2014 |
David Sinclair Ferguson, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20110264744 | CACHE STRUCTURE FOR PEER-TO-PEER DISTRIBUTION OF DIGITAL OBJECTS - A method for the distribution of digital objects in a peer-to-peer network is disclosed. The digital objects are distributed in a plurality of pieces. At least some of a plurality of peers are connected to other ones of the plurality of peers and at least one of the peers is connected to at least one cache. | 10-27-2011 |
David Thomas Ferguson, Sevenoaks GB
Patent application number | Description | Published |
---|---|---|
20150112734 | PARAMETRIC DRAW-DOWN SYSTEM FOR RISK SHARING OF CRITICALILLNESS RISKS AND CORRESPONDING METHOD THEREOF - Proposed are a parametric, event-driven critical illness insurance system based on a resource-pooling system ( | 04-23-2015 |
20150112735 | PARAMETRIC SYSTEM FOR RISK SHARING OF CRITICAL ILLNESS RISKS AND CORRESPONDING METHOD THEREOF - Proposed are a parametric, event-driven critical illness insurance system based on a resource-pooling system ( | 04-23-2015 |
Elaine Ferguson, Cardiff GB
Patent application number | Description | Published |
---|---|---|
20130096049 | THERAPEUTIC CONJUGATES - The invention concerns a novel antimicrobial peptide (AMP) polymer conjugate comprising at least one AMP, typically colistin, and a dextrin polymer wherein said dextrin polymer has a molecular weight between 5,000-60,000 g/mol and is modified by the additions of pendant groups which increase the stability of the conjugate and so delays its degradation thereby slowing the rate at which the AMP is released. | 04-18-2013 |
Eric T. Ferguson, London GB
Patent application number | Description | Published |
---|---|---|
20130262251 | PICKUP LOCATIONS - A pickup location that includes a control station and one or more storage compartment modules provides the ability for items to be ordered and delivered for pickup by a user without having to pack those items in a shipping package prior to shipping from a materials handling facility. Delivering items for pickup by a user without having to package the items prior to shipping, may provide a better experience for the customer, reduce waste in packaging material and a lower cost of delivering the ordered items to the customer. | 10-03-2013 |
20130262336 | PRE-ORDER DELIVERY OF ITEMS TO A PICKUP LOCATION - A pickup location that includes a control station and one or more storage compartment modules provides the ability for items to be ordered and delivered for pickup by a user without having to pack those items in a shipping package prior to shipping from a materials handling facility. Delivering items for pickup by a user without having to package the items prior to shipping, may provide a better experience for the customer, reduce waste in packaging material and a lower cost of delivering the ordered items to the customer. | 10-03-2013 |
Graham Richard Ferguson, Rodborough GB
Patent application number | Description | Published |
---|---|---|
20100156056 | Machine adaptation - The invention relates to the transmission of power and/or data from/to a stationary part of a machine tool | 06-24-2010 |
James Ferguson, Oxon GB
Patent application number | Description | Published |
---|---|---|
20100178391 | FLEXIBLE PAD FOR PREPARING A BEVERAGE - The present invention provides a flexible pad for preparing a beverage comprising: a filter bag defining a storage volume; the storage volume containing a water-soluble composition or a combination or mixture of water-soluble compositions for forming a beverage; wherein the storage volume further contains one or more absorbent elements. | 07-15-2010 |
James Ferguson, Fife GB
Patent application number | Description | Published |
---|---|---|
20090198173 | Light Emitting Device for use in Therapeutic and/or Cosmetic Treatment - An ambulatory device for use in therapeutic and/or cosmetic treatment has a localised light source such as an LED (e.g. | 08-06-2009 |
20110034972 | Therapeutic Light-Emitting Device - An ambulatory device for use in a therapeutic and/or cosmetic treatment, the device comprises an organic light-emitting semiconductor which, in use, covers an area to be treated and emits electromagnetic radiation to cause said therapeutic and/or cosmetic treatment of the area. The light source may be extensive to provide uniform irradiation of the area to be treated and may be pulsed. The device may also include a photopharmaceutical. | 02-10-2011 |
Jennifer Ferguson, Manchester GB
Patent application number | Description | Published |
---|---|---|
20110027779 | POLYNUCLEOTIDE PRIMERS - A polynucleotide comprising at least the final six nucleotides of one of the following primer sequences, or a sequence complementary thereto: SEQ. ID NOS. 3 to 16, 18, 20 to 33, 35 or 37 to 39. A method of detecting the presence or absence of a mutation in the PIK3CA gene, wherein the mutation is one of H1047R, H1047L, E542K and E545K, and preferably ARMS primers are combined with Scorpion primers. | 02-03-2011 |
20140141425 | POLYNUCLEOTIDE PRIMERS FOR DETECTING PIK3CA MUTATIONS - A polynucleotide comprising at least the final six nucleotides of one of the following primer sequences, or a sequence complementary thereto: SEQ. ID NOS. 3 to 16, 18, 20 to 33, 35 or 37 to 39. A method of detecting the presence or absence of a mutation in the PIK3CA gene, wherein the mutation is one of H1047R, H1047L, E542K and E545K, and preferably ARMS primers are combined with Scorpion primers. | 05-22-2014 |
Jeremy Phillip Ferguson, Kidderminster GB
Patent application number | Description | Published |
---|---|---|
20120193294 | DISSOLVED GAS FLOTATION PRESSURE REDUCTION NOZZLE - A dissolved gas flotation pressure reduction nozzle ( | 08-02-2012 |
Jim Ferguson, Oxon GB
Patent application number | Description | Published |
---|---|---|
20090311384 | POD FOR PREPARING A BEVERAGE - A pod for preparing a beverage comprising: a rigid or semi-rigid sidewall; a rigid or semi-rigid upper surface containing one more apertures forming an inlet of the pod; a lower surface formed at least partially from filtering material, the filtering material forming an outlet of the pod; the sidewall, upper surface and lower surface together defining a storage volume extending from the inlet to the outlet and containing a water-soluble composition, or a combination or mixture of water-soluble compositions for forming a beverage; wherein the rigid or semi-rigid sidewall maintains a physical separation of the filtering material and the upper surface during use. | 12-17-2009 |
Joel Ferguson, Belfast GB
Patent application number | Description | Published |
---|---|---|
20110000850 | WATER TREATMENT - A process for the treatment of water comprising at least the steps of: (a) providing the water in laminar flow; and (b) providing bubblefree aeration to the water. The present invention introduces aerobic treatment into wastewater settlement without any hindrance to the settlement process. The present invention is useable for any settlement step or stage, without limitation, the commonest being primary settlement or final settling. | 01-06-2011 |
Jonathan Ferguson, London GB
Patent application number | Description | Published |
---|---|---|
20090077451 | METHOD AND APPARATUS FOR IMPLEMENTING DECODE OPERATIONS IN A DATA PROCESSOR - An improved method and apparatus for performing operations (such as Viterbi decode) in digital processors using a reduced number of cycles. In one aspect, the invention comprises efficient methods for performing multiple “butterfly” add-compare-select (ACS) operations using an improved dual butterfly (DVBF) extension instruction added to the instruction set of a user-configured processor. The DVBF extension allows performance of two butterfly operations in a single cycle. In another aspect, an improved path metric addressing scheme is disclosed. An integrated circuit (IC) device incorporating the aforementioned features, and method of designing such IC, are also disclosed. | 03-19-2009 |
Kennedy Ferguson, Ayrshire GB
Patent application number | Description | Published |
---|---|---|
20120131914 | Power Generation System - A system for generating power is described. The system comprises a gas compressor, a reservoir for storing compressed gas and an apparatus adapted to be located within a body of a liquid. The apparatus comprises at least one chamber in fluid communication with the compressed gas reservoir and an output device. In use, a compressed gas is supplied to the/each chamber from the reservoir, the buoyancy of the gas applying an upward force to a portion of the chamber, the upward force moving at least a portion of the chamber from a first position to a second position, the movement of the at least a portion of the chamber adapted to drive the output device to provide a continuous apparatus output. In at least one embodiment of the invention, heat is extracted from the compressed gas for utilisation in local heating systems. | 05-31-2012 |
Leesa Susanne Ferguson, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20140309121 | Categorisation Of Biological Deposits Using Matrix Assisted Laser Desorption Ionisation Mass Spectrometry - A method of categorising a human according to pre-determined categories using Matrix Assisted Laser Desorption Ionisation Mass Spectrometry (MALDI-MS) is disclosed. A method is provided to discriminate humans based on gender, for example, by comparing MALDI-MS sample spectral data in the m/z range 2,000 to 30,000 and comparing these sample spectral data with reference spectral data obtained from pre-categorised humans. | 10-16-2014 |
Leesa Susanne Ferguson, Sheffield South Yorkshire GB
Patent application number | Description | Published |
---|---|---|
20140084151 | Matrix Assisted Laser Desorption Ionisation Mass Spectrometry Imaging (MALDI-MSI) - A method of preparing a sample for matrix assisted laser desorption ionisation mass spectrometry imaging analysis by a two-step process. Firstly, a MALDI matrix is dusted on to the sample followed by a spray of a suitable solvent onto the dusted sample. The present method has been successfully applied to the detection and mapping of several analyte classes in latent fingermarks. Using the present two-step method, fingermark enhancement, recovery and analysis from different substrate surfaces is now possible enabling visual and chemical information to be obtained simultaneously via remote testing. | 03-27-2014 |
Mark Ferguson, Manchester GB
Patent application number | Description | Published |
---|---|---|
20080207515 | Promotion of Epithelial Regeneration - The invention relates to the use of TGF-β3, or agents having TGF-β3 activity, to promote epithelial regeneration. Methods of manufacturing medicaments, and methods of promoting epithelial regeneration are both provided. In particular, the medicaments and methods of treatment of the invention are applicable to the promotion of epithelial regeneration in healthy patients, and/or in acute wounds. | 08-28-2008 |
Mark Ferguson, Chester GB
Patent application number | Description | Published |
---|---|---|
20120223111 | ACCESSORY HOLDER - A holder for a portable item example mobile phone, comprising an attachment device and a holding device linked by a resilient member. The holder comprises non-slip material and is shaped to securely retain the portable item in the holder whilst allowing the item to remain operable. | 09-06-2012 |
Mark John Ferguson, Inverurie GB
Patent application number | Description | Published |
---|---|---|
20090030364 | Electroporation gene therapy gun system - A cartridge for administration of a bioactive agent may include a plurality of chambers, including at least a first chamber and a second chamber. Each of the chambers may contain a component of a composition to be administered to a tissue site of a subject. For example, the first chamber may contain the bioactive agent and the second chamber may contain a liquid for suspending the bioactive agent prior to administration to the tissue site. An apparatus for administering or delivering a bioactive agent may include the cartridge and may further include an energy source for providing an electrical pulse to the tissue site. The apparatus may further cause mixing of the bioactive agent with the liquid in the cartridge. For example, the apparatus may impact the cartridge to result in mixing of the bioactive agent with the liquid. A method for combining a bioactive agent with a liquid forms a composition for delivering to a tissue site. | 01-29-2009 |
Mark William James Ferguson, Furness Vale GB
Patent application number | Description | Published |
---|---|---|
20150218222 | Medicaments - The present invention relates to the use of a peptide, or derivative thereof of general formula X | 08-06-2015 |
Mark William James Ferguson, Stockport GB
Patent application number | Description | Published |
---|---|---|
20100152095 | Wound healing - A composition for use in the treatment of wounds to inhibit scar tissue formation during healing is disclosed, comprising an effective activity-inhibiting amount of a growth factor neutralising agent or agents specific against only fibrotic growth factors together with a pharmaceutically acceptable carrier. The method of preparation of said composition and method of administering the composition to a host suffering from tissue wounding is also disclosed. | 06-17-2010 |
Mark William James Ferguson, High Peak GB
Patent application number | Description | Published |
---|---|---|
20090144299 | Data storage method - A method for storing data in a database. The method uses configuration data defining an entity and a condition associated with the entity. The method comprises processing a plurality of data items, said processing including determining for each data item whether said condition is satisfied by one of said plurality of data items. If said condition is satisfied by one of said plurality of data items, creating an instance of said entity, said entity being associated with said one data item. | 06-04-2009 |
Mark William James Ferguson, Derbyshire GB
Patent application number | Description | Published |
---|---|---|
20100204248 | MEDICAMENTS AND METHODS FOR INHIBITION OF NON-OCULAR SCARRING - Provided is the use of an agonist of a member of the nuclear hormone receptor NR4A subgroup in the manufacture of a medicament for the prevention, reduction or inhibition of scarring in a non-ocular tissue. Also provided is a method of preventing, reducing or inhibiting scarring in a non-ocular tissue, the method comprising administering a therapeutically effective amount of an agonist of a member of the nuclear hormone receptor NR4A subgroup to a patient in need of such prevention, reduction or inhibition. The NR4A agonist may be 6-mercaptopurine. The medicaments and methods may preferably be used to prevent, reduce or inhibit scarring in the skin. The medicaments and methods of the invention may be used to accelerate healing of wounds. | 08-12-2010 |
20110059896 | USE OF FURIN CONVERTASE INHIBITORS IN THE TREATMENT OF FIBROSIS AND SCARRING - The present invention relates to use of convertase inhibitors for the reduction of scarring during the healing of wounds and also for reducing fibrosis in the treatment of fibrotic conditions. | 03-10-2011 |
Mark Williams James Ferguson, Manchester GB
Patent application number | Description | Published |
---|---|---|
20090083867 | Use of Antagonists of Cxcl13 or Cxcr5 for Treating Wounds of Fibrotic Diseases - The invention provides the use of an antagonist of CXCL 13 or CXCR5 activity in the preparation of a medicament for the prevention and/or inhibition of pathological scarring; as well as the use of such antagonists in the preparation of a medicament for the prevention and/or inhibition of fibrotic disorders; and the use of such antagonists in the preparation of a medicament for the prevention and/or treatment of a chronic wound. Medicaments or methods of the invention are particularly suitable for use in keloids or venous ulcers. Suitable antagonists of CXCL13 or CXCR5 activity may be any compound capable of inhibiting the CXCL13/CXCR5 signalling pathway. The invention also provides a model of aberrant wound healing, which may lead to pathological scar formation, or to chronic wound formation. | 03-26-2009 |
Mark W.j. Ferguson, High Peak GB
Patent application number | Description | Published |
---|---|---|
20120238505 | Medicaments - The present invention relates to the use of a peptide, or derivative thereof of general formula X1-X2-X3-ThT-X4-LyS-X5-ATg-X6 for promoting accelerated wound healing with reduced scarring. X1 is Ala or Gly; X2 is Tyr or Phe; X3, X4 and X5 are independently selected from the group comprising Met, He, Leu and Val; and X6 is selected from the group comprising Asp, Gln and Glu. | 09-20-2012 |
Mark W. J. Ferguson, Manchester GB
Patent application number | Description | Published |
---|---|---|
20100137201 | MEDICAMENTS - There is provided the use of WNT5A, or a therapeutically effective fragment or derivative thereof, in the preparation of a medicament for use in the prevention, reduction or inhibition of scarring. There is also provided the use of WNT5A, or a therapeutically effective fragment or derivative thereof, in the preparation of a medicament for use in the prevention and/or treatment of a fibrotic disorder. Further aspects relate to methods by which scarring may be prevented, reduced or inhibited, and by which fibrotic disorders may be prevented and/or treated. Therapeutically effective amounts of WNT5A, or its fragments or derivatives, that may be used in the medicaments or methods of the invention are also provided. | 06-03-2010 |
20100144690 | MEDICAMENTS AND METHODS FOR PROMOTING WOUND CONTRACTION - Provided are antagonists of FXR activity for use as medicament for the prevention, reduction or inhibition of scarring. This use may preferably be to prevent, reduce or inhibit scarring formed on healing of wounds. The invention also provides corresponding methods of treatment. Preferred antagonists of FXR activity include guggulsterone (Z); guggulsterone (E); a scalarane; 80-574; and a 5α-bile alcohol. In advantageous embodiments, up to 32 μM of the antagonist of FXR activity may be provided per linear cm of wound, or cm | 06-10-2010 |
20100261659 | SECRETED FRIZZLED RELATED PROTEIN 3 FOR USE IN THE INHIBITION OF SCARRING - Provided is secreted Frizzled Related Protein 3 (sFRP3), or a therapeutically effective fragment or derivative thereof, for use as a medicament for the prevention, reduction or inhibition of scarring. The scarring may be associated with the healing of a wound, or with a fibrotic disorder. The scarring may be associated with surgical wounds. The scarring may be scarring of the skin. The medicament may be a topical medicament, and may be suitable for local injection. Also provided is a method of preventing, reducing or inhibiting scarring, the method comprising administering a therapeutically effective amount of sFRP3, or a therapeutically effective fragment or derivative thereof, to a patient in need of such prevention, reduction or inhibition. | 10-14-2010 |
20100286055 | USE OF WNT3A FOR ACCELERATION OF WOUND HEALING - Provided is WNT3A, or a therapeutically effective fragment or derivative thereof, for use as a medicament for accelerating wound healing. Also provided is a method of accelerating wound healing, the method comprising providing a therapeutically effective amount of WNT3 A, or a therapeutically effective fragment or derivative thereof, to a site where wound healing is to be accelerated. The medicaments and methods of the invention may be of particular use in accelerating the healing of skin wounds. | 11-11-2010 |
Natasha Eve Ferguson, Tyne And Waer GB
Patent application number | Description | Published |
---|---|---|
20120103369 | METHOD OF PERFUMING - A method of perfuming in automatic dishwashing comprising the step of providing a first perfume into an automatic dishwashing machine wherein the first perfume is capable of generating a second perfume comprising from about 0.001% to about 10% by weight thereof of a sulphurous compound. | 05-03-2012 |
Neil Samuel Ferguson, London GB
Patent application number | Description | Published |
---|---|---|
20110184905 | METHOD OF STORING AND ANALYSING DATA PRODUCED FROM INTERACTIONS BETWEEN EXTERNAL AGENTS AND A SYSTEM - The present invention relates to a method of storing data records produced from monitoring interactions between external agents and a system. The method comprises defining specific interactions that can occur between the external agents and the system as potential events of interest. A chain of interactions occurring during respective interaction sessions between a respective external agent and the system are monitored and potential events of interest occurring in the said chain are determined. Data records from the monitored chain of interactions are produced, the respective data record including data identifying determined potential events of interest and data associated therewith. A profile identity, representative of the external agent, is assigned to each data record produced during a said interaction session. Data records of individual potential events of interest are stored in a way that is ordered according to the type of potential event of interest and data records of potential events of interest occurring during an interaction session are stored in a way that is ordered according to assigned profile identity. | 07-28-2011 |
Patrick Ferguson, North Shields GB
Patent application number | Description | Published |
---|---|---|
20100308033 | FORMED COMPONENT HEATER ELEMENT - A heater element for formed components is disclosed, along with the final formed component itself. The heater element is produced by photochemically etching a suitable heater track pattern from porous metallised fabric such a nickel coated woven polyester. The heater element is located within a mould. Thermo-formable material is then applied to the mould and the final component is shaped according to the shape of the mould. The final component has a heater element located within it. The component may have microencapsulated agents for initiation by operation of the heater element. Furthermore, the final component may have one or more digital images printed onto the surface for the purposes of decoration or personalisation. | 12-09-2010 |
20100308490 | METHOD OF MANUFACTURING A SHAPED COMPONENT - A heater element for formed components is disclosed, along with the final formed component itself. The heater element is produced by photochemically etching a suitable heater track pattern from porous metallised fabric such a nickel coated woven polyester. The heater element is located within a mould. Thermo-formable material is then applied to the mould and the final component is shaped according to the shape of the mould. The final component has a heater element located within it. The component may have microencapsulated agents for initiation by operation of the heater element. Furthermore, the final component may have one or more digital images printed onto the surface for the purposes of decoration or personalisation. | 12-09-2010 |
Paul A Ferguson, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20090137744 | Polymerisation Of Vinyl Chloride Monomer - A copolymer of (i) an alkyl acrylate or alkyl methacrylate and (ii) a hydroxyalkyl acrylate or hydroxyalkyl methacrylate is used as a secondary protective colloid in the suspension polymerization of vinyl chloride monomer. The alkyl group of the alkyl acrylate or alkyl methacrylate is preferably a 2-ethylhexyl group. The hydroxyalkyl group of the hydroxyalkyl acrylate or hydroxyalkyl methacrylate is preferably a hydroxyethyl group. | 05-28-2009 |
Robert Ferguson, Bristol GB
Patent application number | Description | Published |
---|---|---|
20090007692 | METHOD AND APPARATUS FOR TESTING COMPOSITE MATERIALS - A test coupon has a waisted central section from which respective load introduction sections extend, each load introduction section having a pair of divergent load introduction surfaces extending from a respective curved surface of the central section. Test apparatus includes a test coupon as described above and a plurality of angled pivotable load introduction blocks such that the test coupon may self-align during application of a load. | 01-08-2009 |
Russell John Ferguson, Newmacher GB
Patent application number | Description | Published |
---|---|---|
20080264650 | Method And Apparatus To Position And Protect Control Lines Being Coupled To A Pipe String On A Rig - A control line positioning apparatus ( | 10-30-2008 |
Russell John Ferguson, Aberdeenshire GB
Patent application number | Description | Published |
---|---|---|
20090114399 | END STOP APPARATUS AND METHODS - An adjustable end stop may selectively include one or more of the following elements: at least one guide member, a collapsible member, a movable assembly, a drive mechanism, and a position adjustment mechanism. The guide member may have the collapsible member and/or movable assembly attached thereto. The collapsible member may be configured to collapse when the end of the tubular member engages the collapsible member in a first direction and resist collapsing when the end of the tubular member engages the collapsible member in a second direction. The movable assembly may be movably attached to the at least one guide member, in which the movable assembly is configured to move along at least a portion of the length of the at least one guide rail. Further, the drive mechanism may be used to selectively position the collapsible member and/or movable assembly along the at least one guide member. | 05-07-2009 |
Scott A. Ferguson, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20130217612 | COMPLETE GENOME SEQUENCE OF THE METHANOGEN METHANOBREVIBACTER RUMINANTIUM - The present invention includes the complete genome sequence for the methanogen, | 08-22-2013 |